MedDataX Logo

NIS for Patients Using Symbicort Turbuhaler for Maintenance and Reliever Therapy in a Single Inhaler

NCT ID: NCT00557297

Last Updated: 2008-09-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

250 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-10-31

Study Completion Date

2008-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this non-interventional study is to ensure that patients in routine clinical practice follow given treatment instructions and to evaluate the number of reliever inhalations as well as the number of patient/days with more than 8/12 total inhalations at any day. If the number of reliever inhalations and thus the received inhaled glucocorticosteroid dose is not excessive, the safety conclusions from the clinical studies can be extrapolated to real life for better acceptance of SMART (Symbicort Maintenance and Reliever Therapy).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

asthma SMART inhaled glucocorticosteroid reliever maintenance single inhaler

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Persistent asthma
* Prior Symbicort Turbuhaler maintenance and reliever therapy in a single inhaler
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AstraZeneca

INDUSTRY

Sponsor Role lead

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research Site

Alūksne, , Latvia

Site Status

Research Site

Aozkraukle, , Latvia

Site Status

Research Site

Balvi, , Latvia

Site Status

Research Site

Cēsis, , Latvia

Site Status

Research Site

Gulbene, , Latvia

Site Status

Research Site

Jēkabpils, , Latvia

Site Status

Research Site

Jumprava, , Latvia

Site Status

Research Site

Krāslava, , Latvia

Site Status

Research Site

Kuldīga, , Latvia

Site Status

Research Site

Ķekava, , Latvia

Site Status

Research Site

Liepāja, , Latvia

Site Status

Research Site

Limbaži, , Latvia

Site Status

Research Site

Līvāni, , Latvia

Site Status

Research Site

Madona, , Latvia

Site Status

Research Site

Ogre, , Latvia

Site Status

Research Site

Preiļi, , Latvia

Site Status

Research Site

Rēzekne, , Latvia

Site Status

Research Site

Salacgrīva, , Latvia

Site Status

Research Site

Saldus, , Latvia

Site Status

Research Site

Talsi, , Latvia

Site Status

Research Site

Valniera, , Latvia

Site Status

Research Site

Ventspils, , Latvia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Latvia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

D5890L00031

Identifier Type: -

Identifier Source: org_study_id